Industry Watch
Skipping breakfast and its wide-ranging health consequences: A systematic review from multiple metabolic disruptions to socioeconomic factors
10th September 2025
The aim of the systematic review was to examine the impact of skipping breakfast across multiple health domains. This included diabetes, regulation of weight, composition of gut microbiome, neurodegenerative diseases, cardiovascular health, cancer, immunity, sleep cycles, psychiatric disorders, bone health, athletic performance, socioeconomic factors, and cognitive function.
The systematic review examined the literature from 2010 to 2025 and it evaluated 66 studies.
Semaglutide cuts risk of heart attack, stroke or death compared to tirzepatide in STEER study
10th September 2025
The aim of the STEER study was to examine the real-world occurrence of major adverse cardiovascular event (MACE) while being treated with semaglutide or tirzepatide for chronic weight management in standard clinical practice in the United States.
Semaglutide 2.4 mg (Wegovy®) showed a 57% greater reduction in the risk of stroke, heart attack, or death from any cause, in people with overweight or obesity and cardiovascular disease who remained on the treatment in comparison to tirzepatide. The result was found to be significant.
Ultra-processed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health
27th August 2025
This study examined ultra-processed food diets versus minimally processed food diets following the UK Eatwell Guide, on health outcomes using a randomised crossover trial.
The main aim of the study was to compare the percent of weight change between the diets. The secondary aims were to compare changes in body composition, anthropometrics, cardiometabolic and appetite-related outcomes between the ultra-processed food diets and minimally processed food diets.
Effect of five dietary emulsifiers on inflammation, permeability, and the gut microbiome
27th August 2025
This study examined the effects of an emulsifier-free diet (EFD) and emulsifier supplementation on intestinal permeability and inflammation, gut microbiota and cardiometabolic markers.
The study used a randomised placebo-controlled trial design. The participants had an EFD for two weeks. The participants then continued on an EFD for four weeks with the addition of either polysorbate-80, carrageenan, soy lecithin, carboxymethyl cellulose (CMC), native rice starch (NRS), or no additives supplied through brownies.
Eating chips three times a week raises type 2 diabetes risk by 20%, study finds
12th August 2025
Eating french fries three times a week increases the risk of people getting type 2 diabetes by 20%; doing this five times a week increases the risk by 27% – according to a study published in the British Medical Journal.
The results confirm that potatoes do not cause a risk to health, but frying potatoes to make chips, and consuming them regularly, does increase the risk of diagnosis of type 2 diabetes.
The researchers who conducted the study, led by Seyed Mohammad Mousavi, a public health expert at Harvard University, examined the relationship between the intake of potatoes and the risk of acquiring type 2 diabetes.